Clinical trial
Erenumab For Treatment of Hemicrania Continua
NCT04303845 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Erenumab For Treatment of Hemicrania Continua
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- August 4, 2021
- Completion date
- April 6, 2022
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hemicrania continua